Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80
Document › Details

BiondVax Pharmaceuticals Ltd.. (1/28/21). "Press Release: BiondVax Announces Third Quarter 2020 Financial Results & Business Update". Jerusalem.

Organisations Organisation BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV)
  Organisation 2 European Investment Bank (EIB)
  Group EU (govt)
Products Product M-001 universal flu vaccine (BiondVax)
  Product 2 anti-infective drug
Persons Person Reichman, Amir (BiondVax 202103– CEO before GSK Vaccines + Novartis Vaccines + NeuroDerm)
  Person 2 Phillipson, Joshua E. (BiondVax 201707 Business Development Manager)
     


   
Record changed: 2021-06-05

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Hotspot for Startups 650x80px




» top